Search

The medical industry in India has undergone substantial evolution driven by progress in technology and infrastructure. Yet, prominent hurdles remain when addressing critical problems like inadequate medical infrastructure for the nation's massive population, restricted accessibility, a deficit of qualified practitioners, and high-quality services. Artificial intelligence (AI)-based interventions offer the possibility to ease the burden on the Indian medical network; nevertheless, incorporating reliable AI into this domain is still obstructed by moral and legal barriers. The objective of this research is to critically analyze the contemporary state of AI system engineering in Indian medical care and its alignment with the moral and legal dimensions of AI, while also pinpointing the obstacles and prospects for implementing reliable AI within the Indian medical domain. This investigation assessed 15 papers chosen from an initial pool of 1136 papers collected across two digital databases, PubMed and Google Scholar, alongside project sites. This inquiry utilizes the Preferred Reporting Items for Systematic Reviews and Meta-Analyses Extension for Scoping Reviews (PRISMA-ScR). The findings indicate that current publications primarily deployed traditional machine learning (ML) models and artificial neural networks (ANNs) for diverse operations, including drug discovery, disease monitoring networks, early sickness identification and diagnostic precision, and medical resource administration in India. This analysis uncovers a deficiency in the integration of reliable AI within Indian medical care and various obstructions linked to it. It examines pathways for engineering reliable AI within Indian medical environments, prioritizing patient protection, information confidentiality, and adherence to moral and statutory criteria.

This research undertook an assessment of Large Language Models (LLMs) within the domain of clinical diagnostics, specifically investigating their capacity to interpret symptom-centered inputs and generate precise clinical assessments. The investigation focused on evaluating several prominent architectures—including GPT-4, GPT-4o, Gemini, o1 Preview, and GPT-3.5—to gauge their proficiency in identifying clinical conditions solely from presented symptomatology. To guarantee clinical validity and appropriateness, symptom profiles were compiled from verified medical literature. Each architecture underwent testing within standardized environments to quantify diagnostic accuracy, precision, recall, and underlying logical processing. Specialized clinical scenarios were structured to examine performance boundaries across both routine and critical diagnostic conditions. The findings indicated that GPT-4 delivered the highest overall diagnostic accuracy, displaying a strong synergy with established medical logic. Conversely, Gemini demonstrated superior performance in high-stakes environments where exact decision-making is vital. Both GPT-4o and o1 Preview presented equitable metrics, maintaining a stable balance between precision and recall while managing real-time diagnostic scenarios. While possessing less advanced capabilities, GPT-3.5 remained functional for standard diagnostic duties. Ultimately, this investigation outlines the current capabilities and constraints of utilizing LLMs for clinical determination. Even though architectures like GPT-4 and Gemini show significant capability, critical barriers regarding data confidentiality, ethical protocols, and training bias correction must still be overcome. These insights offer strategic directions for the ethical incorporation of LLMs into diagnostic frameworks to optimize patient care outcomes.

This review investigates the expanding influence of machine learning and deep learning methodologies within the healthcare sector, concentrating specifically on the vital challenges of interpretability and explainability inherent in black-box models. Although machine learning frameworks are increasingly deployed to assist in medical analytics and diagnostics, their intricate nature emphasizes the necessity of comprehending how these systems process and interpret data to facilitate well-informed clinical choices. This paper offers a thorough examination of the obstacles and potential solutions documented in existing scholarship, delivering a synthesis of contemporary techniques in this domain. Furthermore, it establishes precise conceptual boundaries for interpretability and explainability, seeking to untangle the differences between these notions and outline their consequences for clinical decision-making. Utilizing a dataset of 448 publications to address seven distinct research questions, our investigation demonstrates that this research area has experienced exponential growth over the past ten years. Additionally, the psychological factors governing public opinion highlight the vital need for transparent communication regarding the capabilities and constraints of artificial intelligence. To mitigate opacity, investigators are actively engineering strategies to lower model complexity and implement visual explanation tools. Nevertheless, maintaining a delicate equilibrium between high predictive performance and adequate model interpretability remains an ongoing challenge. Given the expanding role of artificial intelligence in supporting clinical diagnostics and therapeutics, the development of inherently interpretable artificial intelligence systems is critical. Within this rapidly changing paradigm, a steadfast dedication to transparency, ethical standards, and cross-disciplinary partnerships is essential to guarantee the conscientious deployment of artificial intelligence. This shared dedication is foundational to cementing long-term trust between medical professionals and patients, resolving novel problems, and promoting the educated integration of these sophisticated technologies into medical practices.

The integration of deep learning (DL) algorithms offers significant potential to enhance healthcare applications. Specifically, DL has advanced medical imaging diagnostics, therapeutic interventions, and disease management. However, deploying deep learning algorithms on sensitive medical imagery introduces substantial challenges regarding data security and patient privacy. Optimizing medical imaging performance while simultaneously ensuring patient anonymity remains a complex task. Consequently, privacy-preserving techniques designed for deep learning model training and inference are increasingly gaining traction. Currently, these medical image sequences are interpreted using state-of-the-art computer-aided detection/diagnosis (CAD) methodologies. Yet, frameworks that require uploading medical photographs to external servers inherently create privacy vulnerabilities.To address this, this article introduces a convolutional Bi-LSTM network designed to evaluate fully homomorphic-encrypted (HE) time-series medical images. Within this framework, convolutional blocks extract selective spatial features from the secure image sequences, while analytical sequence layers based on Bi-LSTM encode the temporal data. To optimize efficiency and minimize misdiagnoses, a weighted unit and sequence voting layer incorporates spatial data using varying weights. The effectiveness of this framework is demonstrated using two rigorous public benchmarks: the CheXpert and BreaKHis datasets. The proposed technique surpasses several competing methods, achieving an accuracy exceeding 0.99 across both datasets. These findings indicate that the introduced methodology can successfully extract visual representations and sequential dynamics from encrypted medical image series, thereby safeguarding patient privacy while maintaining high performance in medical image analysis.